Publication date: Dec 04, 2024
Some children and young people (CYP) infected with SARS-COV-2 experience impairing symptoms post-infection, known as post-COVID-19 condition (PCC). Using data from the National Long COVID in Children and Young People (CloCk) study, we report symptoms and their impact up to 24-months post-infection. CloCk is a cohort of CYP in England aged 11-to-17-years when they had a SARS-CoV-2 PCR-test (between September 2020 and March 2021). Of 31,012 eligible CYP 24-months post-PCR test, 12,632 participated (response = 40. 7%). CYP were grouped by infection status: ‘initial test-negatives; no subsequent positive-test’ (NN); ‘initial test-negatives; subsequent positive-test’ (NP); ‘initial test-positives; no reported re-infection’ (PN); and ‘initial test-positives; reported re-infection’ (PP). The Delphi research definition of PCC in CYP was operationalised; symptom severity/impact and validated scales (e. g., Chalder Fatigue Scale) were recorded. We examine symptom profiles 24-month post-index-test by infection status. 7. 2% of CYP consistently fulfil the PCC definition at 3-, 6-, 12- and 24-months. These CYPs have a median of 5-to-6 symptoms at each time-point. Between 20% and 25% of all infection status groups report 3+ symptoms 24-months post-testing; 10-25% experience 5+ symptoms. The reinfected group has more symptoms than the other positive groups; the NN group has the lowest symptom burden (p
Concepts | Keywords |
---|---|
Fatigue | Covid |
Months | Cyp |
Pcr | Infection |
Initial | |
Month | |
Months | |
National | |
Pcc | |
Positive | |
Post | |
Status | |
Symptom | |
Symptoms | |
Test | |
Young |
Semantics
Type | Source | Name |
---|---|---|
disease | MESH | COVID-19 |
disease | MESH | infection |
drug | DRUGBANK | Factor IX Complex (Human) |
disease | MESH | Long COVID |
disease | MESH | re-infection |
disease | IDO | symptom |
disease | MESH | symptom burden |